Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disentangling Effects of Oxytocin on Cognitive and Reactive Fear and the Moderating Role of the Receptor for Advanced Glycation End-products

NCT04292444 is registered in ClinicalTrials.gov with University Hospital, Bonn as lead sponsor.

NCT NCT04292444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04292444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disentangling Effects of Oxytocin on Cognitive and Reactive Fear and the Moderating Role of the Receptor for Advanced Glycation End-products
Lead sponsor
University Hospital, Bonn
Phase
Phase 1
Overall status
Unknown status
Start date
December 13, 2019
Completion date
May 31, 2021
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oxytocin